Biosearch Technologies Responds To China Influenza H7N9 Outbreak By Providing H7N9 Detection Panel

ValuPanel ReagentsUpdated : Mon, September 19, 2022 @ 2:13 PM

Biosearch Technologies, Inc. (Biosearch) announced today that the company has implemented a rapid response to the current outbreak of Avian Influenza Virus A (H7N9) in China.  Biosearch is ready to provide to the scientific community on-demand, rapid synthesis of real-time qPCR probes and primers composing the H7N9 detection panel recently developed and published on 8 April by the World Health Organization (WHO) Collaborating Center for Reference and Research on Influenza in Beijing, China.  WHO lists FAM-BHQ® probes as crucial reagents in their protocol named, “Real-time RT-PCR Protocol for the Detection of A(H7N9) Influenza Virus,” which is available for download at:  

To read the entire story, here's the full press release.


Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!